Only half of pediatric patients with vitiligo receive treatment within 2 years of diagnosis, a US study reports.

Leading companies, such as Incyte Corporation, TWi Biotechnology, Amgen, Pfizer, Arcutis Biotherapeutics, AnaptysBio, and others, are actively advancing promising drug candidates aimed at improving ...

Conversations with entrepreneurs, technologists, and researchers on emerging technologies and the importance of STEM in drug discovery.

Vitiligo, an autoimmune disease that causes areas of skin to lose pigment and appear white, is a lifelong condition. While it can’t be cured, several treatment options, including medications ...

An expert discusses how vitiligo significantly affects patients’ psychosocial health due to its visible nature, unpredictable course, slow treatment response, and particularly severe impact on younger ...

An expert discusses how vitiligo patients commonly develop thyroid disease as a comorbidity and face increased skin cancer risk while highlighting the urgent need for new treatments beyond the single ...

Niels Finsen's groundbreaking work with light therapy revolutionized medical treatment, earning him the Nobel Prize in 1903.

Incyte could be a few month away from a second FDA approval for its Opzelura cream that would make it the first medical treatment to re-pigment the skin of people with vitiligo. The FDA has kicked ...

Joao first learned how to make rugs and animal shapes with yarn. Once he got the hang of it, he decided to make something ...

Clinuvel also focuses on increasing coverage and reimbursement support. In the US, Scenesse is well covered by over 100 national and local private insurers, as well as Medicare and Medicaid. Billing ...

Despite no major announcements, shares in Clinuvel Pharmaceuticals ( ASX: CUV) have declined roughly by another 15% since ...